Cepheid
Adilia Morales, MD, MPH, MND, currently serves as Director and Global Danaher Business System Leader for the Americas at Cepheid since January 2021. Prior experience includes a role as Process Improvement Consultant at Sutter Health from June 2016 to January 2021, where Adilia coached executives on business enhancements and led project initiatives. As Multisite Director and Clinic Manager at Seton Medical Center from July 2013 to March 2016, responsibilities included overseeing multiple outpatient departments. Earlier roles involved serving as a Bilingual Health Educator and Case Manager at San Benito Health Foundation, and working as a travel medical doctor and educator with VIDA Volunteer Travel and Global Medical Training. Academic qualifications include a Doctorate in Medicine from Latin American Medical School, a Master in Public Health from Kaplan University, and a Master in Nutrition and Dietetics from Cadiz University.
Cepheid
9 followers
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.